Expression of HBcAg in hepatocytes and its association with the efficacy of antiviral therapy

Expression of HBcAg in hepatocytes and its association with the efficacy of antiviral therapy

ObjectiveTo investigate the effect of the expression of HBcAg in hepatocytes on the serum level of HBcAb and seroconversion of HBeAg after antiviral therapy with nucleos(t)ide analogues (NUCs). MethodsSerum samples and liver tissue paraffin sections were collected from 101 chronic hepatitis B (CHB)...

Full description

Bibliographic Details
Main Author:	FU Xihua
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2021-06-01
Series:	Linchuang Gandanbing Zazhi
Online Access:	http://www.lcgdbzz.org/cn/article/doi/10.3969/j.issn.1001-5256.2021.06.017

Similar Items

Association of the expression of HBsAg and HBcAg in liver tissue with antiviral response in children with chronic hepatitis B
by: WANG Limin
Published: (2021-01-01)

Expression of HBcAg fusion proteins in yeast and an investigation of their immunological properties
by: Beesley, Katrina M.
Published: (1991)

The Effects of HBcAg and HBeAg on the Expression of Cytokine Genes from Murine Macrophages
by: Kung-yen Chang, et al.
Published: (1999)

The T cell probiferative response to HBcAg in hepatitis B virus carriers
by: SHEN, CHING-HUNG, et al.
Published: (1992)

Cloning of the Core Antigen (HBcAg) Gene of Hepatitis B Virus into an Eucaryotic Expression Vector
by: Yasemin BULUT, et al.
Published: (2003-06-01)

Generation of fusion protein EGFRvIII-HBcAg and its anti-tumor effect in vivo
by: Zhang Ming-xin, et al.
Published: (2009-09-01)

Expression of HBsAg and HBcAg in liver biopsy specimens of chronic B hepatitis patients and its relation with histology activity index
by: Budiana Tanurahardja, et al.
Published: (1996-07-01)

Establishment and functional evaluation of DC-CIK co-culture system with combined loading of HBsAg and HBcAg
by: WANG Shaoyang, et al.
Published: (2017-07-01)

Construction and expression of indonesian hepatitis B core antigen (HBcAg) in Lactococcus lactis as potential therapeutic vaccine
by: Rahma Isartina Anwar, et al.
Published: (2019-03-01)

Change and significance of HBcAg-specific Th22 cells in patients with hepatitis B virus infection
by: JIN Juan
Published: (2020-11-01)

In vitro expression of precore proteins of hepatitis B virus subgenotype A1 is affected by HBcAg, and can affect HBsAg secretion
by: Aurélie Deroubaix, et al.
Published: (2021-04-01)

Relationship between HBV DNA and HBeAg in serum and HBcAg and inflammation grade in liver tissue among patients with chronic hepatitis B
by: LIU Xingxiang
Published: (2013-12-01)

Adenovirus Vector Harboring the HBcAg and Tripeptidyl Peptidase II Genes Induces Potent Cellular Immune Responses In Vivo
by: Quanhui Tan, et al.
Published: (2017-01-01)

Removal of Hepatitis B virus surface HBsAg and core HBcAg antigens using microbial fuel cells producing electricity from human urine
by: Grzegorz Pasternak, et al.
Published: (2019-08-01)

CemX Peptide-carrying HBcAg Virus-like Particles Induced Antibodies that Down-regulate mIgE-B lymphocytes
by: 林健仁
Published: (2013)

Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide
by: Jens Schumacher, et al.
Published: (2018-04-01)

Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model
by: Chu X, et al.
Published: (2016-05-01)

Application of <i>In-Situ</i> and Soft-Sensors for Estimation of Recombinant <i>P. pastoris</i> GS115 Biomass Concentration: A Case Analysis of HBcAg (Mut<sup>+</sup>) and HBsAg (Mut<sup>S</sup>) Production Processes under Varying Conditions
by: Oskars Grigs, et al.
Published: (2021-02-01)

Prevalence of Anti-HBc Antibodies among HBsAg Negative Individuals and Its Association with Occult Hepatitis B
by: Anitha Madhavan, et al.
Published: (2021-03-01)

Reactivation risk of Hepatitis B Virus in both HBsAg negative and HBcIgG positive patients with solid malignancy. Is antiviral prophylaxis really necessary?
by: Murat Araz, et al.
Published: (2019-06-01)

Seroprevalence of HbsAg, anti-HBc and anti-HCV in Southern Brazil, 1999-2001
by: Nilton Rosini, et al.

Seroprevalence of HbsAg, anti-HBc and anti-HCV in Southern Brazil, 1999-2001
by: Rosini Nilton, et al.
Published: (2003-01-01)

GAMBARAN ANTI HBc POSITIF PADA DONOR DARAH DENGAN HbsAG NEGATIF
by: Susila Sastri
Published: (2009-09-01)

Prevalence of HBc-Ab among HBs-Ag negative healthy blood donors in south of Iran
by: Farhad Khorami, et al.
Published: (2013-03-01)

Clinical characteristics of patients with HBsAg(+) versus HBsAg(-)/HBcAb(+) primary hepatic carcinoma treated by hepatectomy: a comparative analysis
by: YANG Keli
Published: (2015-06-01)

Long-Term Safety in HBsAg-Negative, HBcAb-Positive Patients with Rheumatic Diseases Receiving Maintained Steroid Therapy after Pulse Therapy
by: Ying-Cheng Lin, et al.
Published: (2021-07-01)

Influence of quantitative changes in HBeAg on the therapeutic efficacy of antiviral drugs
by: XIE Zhiwei
Published: (2013-02-01)

Isolated Anti-HBc: Significance and Management
by: Florian MORETTO, et al.
Published: (2020-01-01)

Prevalências do HBsAg, do anti-HBc e do anti-HCV na população de candidatos a doadores de sangue do Hemocentro-Campinas Prevalence of HBsAg, anti-HBc and anti-HCV in the blood donors of "Hemocentro-Campinas"
by: Fernando Lopes Gonçales Júnior, et al.
Published: (1993-02-01)

Effect of entecavir antiviral therapy on expression of PD-1 of peripheral T lymphocytes in CHB patients and its relationship with serum HBeAg
by: Hong Xia, et al.
Published: (2016-04-01)

The Positivity Ratios of HBsAg, Anti-HBs and Isolated Anti-HBc in Patients with Breast and Gynecologic Cancers Prior to Chemotherapy
by: Ayşe İnci, et al.
Published: (2018-06-01)

numbers of PFCanti-HBc in patients with chronic Hepatitis
by: Baghdad Science Journal
Published: (2006-03-01)

Incidence of anti-HBc antibody (IgG and IgM) among HBsAg negative apparently healthy blood donors
by: Nittyananda Shil, et al.
Published: (2016-12-01)

The Efficacy of the Hepatocyte Spheroids for Hepatocyte Transplantation
by: Kazuaki Shibuya, et al.
Published: (2021-04-01)

Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C
by: Nicola Coppola, et al.
Published: (2014-01-01)

Meta-omics characteristics of intestinal microbiota associated to HBeAg seroconversion induced by oral antiviral therapy
by: Yu-Li Zeng, et al.
Published: (2021-02-01)

Clinical value of anti-HBc quantification for chronic HBV infection
by: HOU Fengqin, et al.
Published: (2018-05-01)

Association of late-onset postpartum depression of mothers with expressive language development during infancy and early childhood: the HBC study
by: Sona-Sanae Aoyagi, et al.
Published: (2019-03-01)

First-line oral antiviral therapies showed similar efficacies in suppression of serum HBcrAg in chronic hepatitis B patients
by: Lung-Yi Mak, et al.
Published: (2021-03-01)

Hepatitis B Reactivation in a HBsAg-Negative, HBcAb-Positive Patient Receiving Fludarabine for the Treatment of Chronic Lymphocytic Leukaemia
by: Federica Toscanini, et al.
Published: (2011-01-01)